3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Neoplasms
1
Melanoma
1
Diabetes Mellitus
1
Dementia
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Cancer Female
1
Atherosclerosis
1
Interventions
sofosbuvir-velpatasvir drug combination
1
amlodipine, atorvastatin drug combination
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Rosuvastatin Calcium
1
Progesterone
1
Omeprazole
1
Naproxen
1
Liraglutide
1
Gonadotropin-Releasing Hormone
1
Geritol
1
Folic Acid
1
Febuxostat
1
Estradiol
1
Colchicine
1
Cholecalciferol
1
Chocolate
1
Atorvastatin
1
Antirheumatic Agents
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cardiovascular Diseases
×
Atorvastatin
×
Clear all
NCT02099123
2024-11-21
STAREE
Monash University
Phase 4
Active not recruiting
9,971 enrolled